每年研究成果
每年研究成果
- 12結果
搜尋結果
-
2024
Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice
Kung, M. L., Cheng, S. M., Wang, Y. H., Cheng, K. P., Li, Y. L., Hsiao, Y. T., Tan, B. C. M. & Chen, Y. W., 2024 12月, 於: Communications Biology. 7, 1, 594.研究成果: Article › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
2023
Calsarcin-2 May Play a Compensatory Role in the Development of Obese Sarcopenia
Liang, Y. C., Cheng, K. P., Kuo, H. Y., Wang, C. T., Chou, H. W., Huang, K. L., Wu, H. T. & Ou, H. Y., 2023 10月, 於: Biomedicines. 11, 10, 2708.研究成果: Article › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Growth differentiation factor-15 is independently associated with metabolic syndrome and hyperglycemia in non-elderly subjects
Ho, L. C., Wu, H. T., Hung, H. C., Chou, H. W., Cheng, K. P., Lin, C. H., Wang, C. C. & Ou, H. Y., 2023 1月 1, 於: BioFactors. 49, 1, p. 119-126 8 p.研究成果: Article › 同行評審
5 引文 斯高帕斯（Scopus） -
2022
Beyond Sarcopenia: older adults with type II diabetes mellitus tend to experience an elevated risk of poor dynamic balance—a case–control study
Lin, C. C., Ou, H. Y., Hsu, H. Y., Cheng, K. P., Hsieh, T. J., Yeh, C. H., Su, F. C. & Kuo, L. C., 2022 12月, 於: BMC geriatrics. 22, 1, 138.研究成果: Article › 同行評審
開啟存取9 引文 斯高帕斯（Scopus） -
Real-World Comparative Evaluation of Add-On Glucagon-like Peptide 1 Receptor Agonist in Type 2 Diabetes Treated with or without Insulin
Chou, H. W., Cheng, K. P., Lin, A. C., Hung, H. C., Lin, C. H., Wang, C. C., Wu, H. T. & Ou, H. Y., 2022 12月, 於: Pharmaceuticals. 15, 12, 1569.研究成果: Article › 同行評審
開啟存取 -
Sucralose, a Non-nutritive Artificial Sweetener Exacerbates High Fat Diet-Induced Hepatic Steatosis Through Taste Receptor Type 1 Member 3
Wu, H. T., Lin, C. H., Pai, H. L., Chen, Y. C., Cheng, K. P., Kuo, H. Y., Li, C. H. & Ou, H. Y., 2022 5月 23, 於: Frontiers in Nutrition. 9, 823723.研究成果: Article › 同行評審
開啟存取18 引文 斯高帕斯（Scopus） -
2021
The serum concentrations of hedgehog-interacting protein, a novel biomarker, were decreased in overweight or obese subjects
Chou, H. W., Hung, H. C., Lin, C. H., Lin, A. C., Du, Y. F., Cheng, K. P., Li, C. H., Chang, C. J., Wu, H. T. & Ou, H. Y., 2021 2月 2, 於: Journal of Clinical Medicine. 10, 4, p. 1-8 8 p., 742.研究成果: Article › 同行評審
開啟存取5 引文 斯高帕斯（Scopus） -
2020
Discovery of a role of the novel hepatokine, hepassocin, in obesity
Huang, R. L., Li, C. H., Du, Y. F., Cheng, K. P., Lin, C. H., Hu, C. Y., Wu, J. S., Chang, C. J., Wu, H. T. & Ou, H. Y., 2020 1月 1, 於: BioFactors. 46, 1, p. 100-105 6 p.研究成果: Article › 同行評審
16 引文 斯高帕斯（Scopus） -
2019
Elevated hedgehog-interacting protein levels in subjects with prediabetes and type 2 diabetes
Lin, A. C., Hung, H. C., Chen, Y. W., Cheng, K. P., Li, C. H., Lin, C. H., Chang, C. J., Wu, H. T. & Ou, H. Y., 2019 10月, 於: Journal of Clinical Medicine. 8, 10, 1635.研究成果: Article › 同行評審
開啟存取12 引文 斯高帕斯（Scopus） -
Helicobacter pylori eradication improves glycemic control in type 2 diabetes patients with asymptomatic active Helicobacter pylori infection
Cheng, K. P., Yang, Y. J., Hung, H. C., Lin, C. H., Wu, C. T., Hung, M. H., Sheu, B. S. & Ou, H. Y., 2019 7月, 於: Journal of Diabetes Investigation. 10, 4, p. 1092-1101 10 p.研究成果: Article › 同行評審
開啟存取21 引文 斯高帕斯（Scopus） -
Serum secretogranin III concentrations were increased in subjects with metabolic syndrome and independently associated with fasting plasma glucose levels
Lin, C. C., Cheng, K. P., Hung, H. C., Li, C. H., Lin, C. H., Chang, C. J., Hu, C. Y., Wu, H. T. & Ou, H. Y., 2019 9月, 於: Journal of Clinical Medicine. 8, 9, 1436.研究成果: Article › 同行評審
開啟存取4 引文 斯高帕斯（Scopus） -
2018
Unsaturated Fatty Acids Increase the Expression of Hepassocin through a Signal Transducer and Activator of Transcription 3-Dependent Pathway in HepG2 Cells
Cheng, K. P., Ou, H. Y., Hung, H. C., Li, C. H., Fan, K. C., Wu, J. S., Wu, H. T. & Chang, C. J., 2018 9月, 於: Lipids. 53, 9, p. 863-869 7 p.研究成果: Article › 同行評審
13 引文 斯高帕斯（Scopus）